- Trials with a EudraCT protocol (93)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
93 result(s) found for: COVID-19 Vaccines.
Displaying page 2 of 5.
EudraCT Number: 2021-002186-17 | Sponsor Protocol Number: volgt | Start Date*: 2021-08-31 |
Sponsor Name:RadboudUMC | ||
Full Title: Timing and sequence of vaccination against COVID-19 and Influenza | ||
Medical condition: Immunogenicity of the consecutive vaccination with both an mRNA COVID-19 vaccin and Influenza vaccin, in different sequences | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: NL (Completed) | ||
Trial results: View results |
EudraCT Number: 2021-001080-24 | Sponsor Protocol Number: NL76906.068.21 | Start Date*: 2021-04-08 |
Sponsor Name:Maastricht University | ||
Full Title: The effect of plant stanol ester consumption on the vaccination response to a COVID-19 vaccine | ||
Medical condition: COVID-19 vaccination respons of people with BMI 27-35 kg/m2 | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: NL (Prematurely Ended) | ||
Trial results: View results |
EudraCT Number: 2020-002503-19 | Sponsor Protocol Number: 62586 | Start Date*: 2020-07-08 | |||||||||||
Sponsor Name:UMC Utrecht | |||||||||||||
Full Title: BCG vaccination to Reduce the impact of COVID-19 in healthcare workers (BRACE) Trial | |||||||||||||
Medical condition: SARS-CoV-2 infection | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: NL (Completed) GB (GB - no longer in EU/EEA) | |||||||||||||
Trial results: View results |
EudraCT Number: 2021-003188-90 | Sponsor Protocol Number: ENFORCE-PLUS | Start Date*: 2021-07-01 | |||||||||||
Sponsor Name:CHIP - Rigshospitalet - University of Copenhagen | |||||||||||||
Full Title: A Phase IV Vaccine Study under the National Cohort Study of Effectiveness and Safety of SARS-CoV-2/Covid-19 vaccines (ENFORCE PLUS) | |||||||||||||
Medical condition: The primary objective of the study is to assess if the SARS-CoV-2 vaccine Johnson & Johnson/Janssen results in change in number and activation of platelets and anti-PF4 level. As well as to compare... | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: DK (Prematurely Ended) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2021-000930-32 | Sponsor Protocol Number: SJ2021005 | Start Date*: 2021-04-27 |
Sponsor Name:AZ Sint-Jan Brugge-Oostende AV | ||
Full Title: COVID-19: Documentation of humoral and cellular immune response of hemodialysis patients after vaccination against SARS-CoV-2 | ||
Medical condition: hemodialysis patients hemodialysis patients with comorbidities | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: BE (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2021-005094-28 | Sponsor Protocol Number: VAC3_COVID-19_antibody_study_V1 | Start Date*: 2021-10-21 |
Sponsor Name:Medical University of Vienna, Department for Internal Medicine III, Division of Rheumatology | ||
Full Title: Population-based prospective, clinical study on efficacy and safety of a booster COVID-19 vaccination | ||
Medical condition: SARS-CoV-2 infection prevention | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: AT (Completed) | ||
Trial results: View results |
EudraCT Number: 2021-002984-23 | Sponsor Protocol Number: 33-391ex20/21 | Start Date*: 2021-08-01 |
Sponsor Name:Medical University of Graz | ||
Full Title: Retrospective quantification of anti-SARS-CoV-2 antibody response after mRNA COVID-19 vaccine in patients treated with peritoneal dialysis | ||
Medical condition: Chronic peritoneal dialysis patients | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: AT (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2021-000440-22 | Sponsor Protocol Number: Version17032021 | Start Date*: 2021-03-25 |
Sponsor Name:Universiteit Antwerpen | ||
Full Title: Vaccination against COVID-19 in Pregnant and Lactating Women in Belgium | ||
Medical condition: Vaccine responses to COVID19 vaccines administered in pregnant and lactating women | ||
Disease: | ||
Population Age: Adults | Gender: Female | |
Trial protocol: BE (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2020-003370-41 | Sponsor Protocol Number: VAT00002 | Start Date*: 2021-08-23 | |||||||||||
Sponsor Name:Sanofi Pasteur Inc. | |||||||||||||
Full Title: Immunogenicity and Safety of SARS-CoV-2 Recombinant Protein Vaccines with AS03 Adjuvant in Adults 18 Years of Age and Older as a Primary Series and Immunogenicity and Safety of a Booster Dose of SA... | |||||||||||||
Medical condition: COVID-19 | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: ES (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2021-000349-42 | Sponsor Protocol Number: DurIRVac-1 | Start Date*: 2021-03-26 |
Sponsor Name:Sahlgrenska Academy, University of Gothenburg | ||
Full Title: Evaluation of the Durability of Immune Responses to SARS-CoV-2 Using Novel Rapid Spike Interferon-Gamma Release and Activation-Induced Marker Assays and Anti-Spike IgG Following COVID-19 Vaccination | ||
Medical condition: COVID-19 | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: SE (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2021-001393-31 | Sponsor Protocol Number: ABNCoV2-01 | Start Date*: 2021-08-12 | |||||||||||
Sponsor Name:Bavarian Nordic A/S | |||||||||||||
Full Title: An Open Label Phase 2 Trial to Evaluate the Safety, Tolerability and Immunogenicity of the ABNCoV2 Vaccine in SARS-CoV-2 Seronegative and Seropositive Adult Subjects. | |||||||||||||
Medical condition: COVID-19 disease | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2022-000063-51 | Sponsor Protocol Number: mRNA-1273-P305 | Start Date*: 2024-01-01 |
Sponsor Name:ModernaTX, Inc. | ||
Full Title: A Phase 2/3, Randomized, Observer-blind, Active-controlled, Multicenter Study to Evaluate the Immunogenicity and Safety of Omicron Variant Vaccines in Comparison with mRNA-1273 (Prototype) Booster ... | ||
Medical condition: SARS-CoV-2 | ||
Disease: | ||
Population Age: Adolescents, Under 18, Adults, Elderly | Gender: Male, Female | |
Trial protocol: Outside EU/EEA | ||
Trial results: (No results available) |
EudraCT Number: 2021-003386-35 | Sponsor Protocol Number: INSIGHT-016 | Start Date*: 2021-09-01 | |||||||||||
Sponsor Name:Regents of the University of Minesota | |||||||||||||
Full Title: SARS-CoV-2 vaccination strategies in previous hospitalised and recovered COVID-19 patients | |||||||||||||
Medical condition: Participants of the ACTIV-3/TICO clinical trial at selected sites who received certain pre-specified blinded investigational agents or placebo as part of that trial, and who have since achieved sus... | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DK (Prematurely Ended) ES (Ongoing) | |||||||||||||
Trial results: View results |
EudraCT Number: 2021-003953-43 | Sponsor Protocol Number: VAC31518COV3005 | Start Date*: 2021-11-29 | ||||||||||||||||
Sponsor Name:Janssen Vaccines & Prevention B.V. | ||||||||||||||||||
Full Title: A Randomized, Double-blind, Phase 3 Study to Evaluate Safety, Reactogenicity, and Immunogenicity of Co-administration of Ad26.COV2.S and Influenza Vaccines in Healthy Adults 18 Years of Age and Older | ||||||||||||||||||
Medical condition: Healthy Volunteers (Prevention of COVID-19 and influenza) | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: PL (Completed) BE (Completed) | ||||||||||||||||||
Trial results: View results |
EudraCT Number: 2020-005752-38 | Sponsor Protocol Number: CBAF312ADE03 | Start Date*: 2021-03-18 |
Sponsor Name:Novartis Pharma GmbH | ||
Full Title: An open-label multicenter study to assess response to SARS-CoV-2 modRNA vaccines in participants with secondary progressive multiple sclerosis treated with Mayzent (siponimod) (AMA-VACC) | ||
Medical condition: secondary progressive multiple sclerosis (SPMS) | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: DE (Completed) | ||
Trial results: View results |
EudraCT Number: 2021-004526-29 | Sponsor Protocol Number: uni-koeln-4602 | Start Date*: 2021-10-19 | ||||||||||||||||||||||||||||||||||||
Sponsor Name:University of Cologne | ||||||||||||||||||||||||||||||||||||||
Full Title: A MULTINATIONAL, PHASE 2, RANDOMISED, ADAPTIVE PROTOCOL TO EVALUATE IMMUNOGENICITY AND REACTOGENICITY OF DIFFERENT COVID-19 VACCINES ADMINISTRATION IN OLDER ADULTS (≥75) ALREADY VACCINATED AGAINST ... | ||||||||||||||||||||||||||||||||||||||
Medical condition: Prevention of COVID-19 infection | ||||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||||
Population Age: Elderly | Gender: Male, Female | |||||||||||||||||||||||||||||||||||||
Trial protocol: DE (Completed) NO (Completed) IE (Completed) ES (Completed) LT (Completed) | ||||||||||||||||||||||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2020-002456-21 | Sponsor Protocol Number: 74082 | Start Date*: 2020-05-28 |
Sponsor Name:Radboudumc | ||
Full Title: Enhancing the BCG-induced trained immunity response by addition of bisphosphonate or MMR vaccine: a possible preventive approach against COVID-19 (BCG-PLUS) | ||
Medical condition: Trained immunity COVID-19 This study will investigate whether oral bisphosphonate supplementation or the MMR vaccine can be used as immune potentiators when simultaneously administered with BCG, t... | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: NL (Completed) | ||
Trial results: View results |
EudraCT Number: 2021-002476-39 | Sponsor Protocol Number: RLX0121 | Start Date*: 2021-07-29 | |||||||||||
Sponsor Name:DOMPé FARMACEUTICI S.P.A. | |||||||||||||
Full Title: Prospective study to evaluate the effects of Raloxifene therapy on SARS-CoV-2 immunity after COVID-19 vaccination | |||||||||||||
Medical condition: The study will be conducted in non-oncological female patients older than 50 years who have received the first dose of a COVID vaccination, or who have received the full vaccination within 8 weeks... | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Female | ||||||||||||
Trial protocol: IT (Prematurely Ended) | |||||||||||||
Trial results: View results |
EudraCT Number: 2021-002245-15 | Sponsor Protocol Number: CCM-RNT-202102 | Start Date*: 2021-05-25 | |||||||||||
Sponsor Name:Charité - Universitätsmedizin Berlin | |||||||||||||
Full Title: A low-interventional study to investigate the efficacy and safety of SARS-CoV-2 vaccines in patients with rheumatic diseases. | |||||||||||||
Medical condition: Auto Immune Rheumatic Diseases (AIRD) and patients without rheumatic autoimmune diseases (control group). | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2021-000710-42 | Sponsor Protocol Number: RR-xx-RTX-COVAC | Start Date*: 2021-03-15 | |||||||||||
Sponsor Name:Sint Maartenskliniek | |||||||||||||
Full Title: The RTX-COVAC study: humoral response to COVID-19 vaccination after rituximab, and relation with dose and vaccination timing. A prospective cohort study. | |||||||||||||
Medical condition: Rheumatoid arthritis | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: NL (Completed) | |||||||||||||
Trial results: (No results available) |
Subscribe to this Search
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
Query did not match any studies.